Loading…
GRCE
Grace Therapeutics, Inc.
NASDAQ· Healthcare· Biotechnology· CUSIP 00439U104
$1.89-3.08%Price as of Oct 17, 12:10 UTC · updated once a day, after the close
At a glance
Grace Therapeutics, Inc. (GRCE) is listed on NASDAQ and classified in Biotechnology, part of the Healthcare sector. It is headquartered in Princeton, United States and has 5 employees. The company is worth $39.76M. Revenue was $100M in fiscal 2022, up 50920.4% from the year before. It reported a net loss of $9.82M. The share price is 63.5% below its 52-week high of $5.18. 2 of the 38 superinvestors we track held it at the end of Q2 2026. The largest position belongs to Ken Griffin (Citadel Advisors), at $793.91K. Over the last 30 days, company insiders bought $325.25K of its stock on the open market and sold none.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Key metrics
- Market cap
- $39.76M
- P/E
- —
- Forward P/E
- —
- P/B
- 0.6x
- Dividend yield
- 0.00%
- Payout
- —
- EPS
- -$1.17
- ROE
- -36.19%
- Profit margin
- 0.00%
- Revenue growth
- —
- Beta
- 0.33
- 52-week high
- $5.18
- 52-week low
- $1.79
History
Year by year, from the annual reports; dividends from the payments themselves.
Bars are year-end balances; lines are what happened during the year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▼ -76.7% over 5Y.
today you would have $188.62▼ -81.1%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 8 closed years, each at that year’s closing price and reported numbers.
| Indicator | Median | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Year-end price | $1.89 | $3.46 | $3.74 | $2.89 | $3.00 | $7.56 | $15.84 | $117.60 | |
| P/S | — | — | — | — | — | 0.2x | 167.4x | — | — |
| P/B | 0.6x | 0.5x | 0.7x | 0.6x | 0.3x | 0.2x | 0.6x |
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| NEPHNephros Inc | $3.65 | 24.3x | 3.3x | 0.00% | 16.10% | $39.64M |
| TILInstil Bio, Inc. | $5.91 | — | 0.4x | 0.00% | -25.33% | $40.08M |
| XTNTXtant Medical Holdings, Inc. | $0.29 | — | 1.0x | 0.00% | -25.16% | $40.22M |
| VERUVERU Inc | $2.30 |
About the company
- 5
- Princeton, United States